🔎 Trials Near Me

Akèy › Kansè poumon › Texas › League City

Etid klinik pou Kansè poumon nan League City, TX

6 etid pou Kansè poumon ap chèche patisipan nan sit nan ak bò kote League City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Ap rekriteFaz 3
  • Houston Methodist Saint John Hospital, Nassau Bay · 3 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT04181060

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Ap rekriteFaz 3
  • Kelsey-Seybold Clinic - Bay Area Campus Building A, Webster · 3 mi lwen
  • Kelsey-Seybold Clinic - Bay Area Campus Building B, Webster · 3 mi lwen
  • Kelsey-Seybold Clinic - Bay Area Campus Building C, Webster · 3 mi lwen
  • ak 1 plis
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07222566

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

Ap rekriteFaz 2
  • University of Texas Medical Branch, Galveston · 23 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07154290

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Ap rekriteFaz 3
  • The University of Texas, MD Anderson Cancer Center - League City, League City
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06758401

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Ap rekriteFaz 3
  • USO - Texas Oncology, Webster · 3 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06119581

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Ap rekriteFaz 3
  • UT MD Anderson - League City, League City
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT05624996

Etid Kansè poumon nan lòt vil

Lòt etid nan League City

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.